Stanley Ress

1.3k total citations
33 papers, 1.0k citations indexed

About

Stanley Ress is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stanley Ress has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 19 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Stanley Ress's work include Tuberculosis Research and Epidemiology (19 papers), Immune Cell Function and Interaction (11 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Stanley Ress is often cited by papers focused on Tuberculosis Research and Epidemiology (19 papers), Immune Cell Function and Interaction (11 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Stanley Ress collaborates with scholars based in South Africa, United States and United Kingdom. Stanley Ress's co-authors include Pauline T. Lukey, Gilla Kaplan, Gregory Hussey, Willem A. Hanekom, Jo‐Ann S. Passmore, Virginia Davids, E. Jane Hughes, Anthony Hawkridge, Rose Ann Murray and Sebastian Gelderbloem and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Stanley Ress

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley Ress South Africa 14 581 581 397 147 108 33 1.0k
Peter Klucar United States 12 611 1.1× 382 0.7× 362 0.9× 168 1.1× 179 1.7× 13 990
T H Rea United States 12 400 0.7× 594 1.0× 545 1.4× 296 2.0× 73 0.7× 21 1.1k
T. Kardjito Indonesia 15 271 0.5× 536 0.9× 396 1.0× 170 1.2× 68 0.6× 35 822
Sok Thim United States 13 397 0.7× 813 1.4× 663 1.7× 308 2.1× 82 0.8× 17 1.2k
Ellen S. DeCarlo United States 12 443 0.8× 623 1.1× 379 1.0× 55 0.4× 108 1.0× 12 1.1k
Rosa Musella Argentina 21 767 1.3× 714 1.2× 572 1.4× 162 1.1× 158 1.5× 40 1.4k
D Kumararatne United Kingdom 15 637 1.1× 410 0.7× 469 1.2× 100 0.7× 112 1.0× 28 1.1k
Marwou de Kock South Africa 16 591 1.0× 715 1.2× 525 1.3× 211 1.4× 117 1.1× 24 1.1k
Patricia Gorak‐Stolinska United Kingdom 15 544 0.9× 343 0.6× 239 0.6× 71 0.5× 121 1.1× 20 875
Victoria Schauf United States 16 241 0.4× 312 0.5× 360 0.9× 116 0.8× 102 0.9× 38 895

Countries citing papers authored by Stanley Ress

Since Specialization
Citations

This map shows the geographic impact of Stanley Ress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley Ress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley Ress more than expected).

Fields of papers citing papers by Stanley Ress

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley Ress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley Ress. The network helps show where Stanley Ress may publish in the future.

Co-authorship network of co-authors of Stanley Ress

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley Ress. A scholar is included among the top collaborators of Stanley Ress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley Ress. Stanley Ress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ress, Stanley. (2014). Investigation of adult immunodeficiency and indications for immunoglobulin replacement therapy. South African Medical Journal. 104(11). 791–791.
2.
Dawson, Rod, Rany Condos, Doris B. Tse, et al.. (2009). Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis. PLoS ONE. 4(9). e6984–e6984. 90 indexed citations
3.
Ress, Stanley. (2008). IMMUNODEFICIENCY DISEASES PRESENTING IN ADULTS - DIAGNOSIS AND MANAGEMENT. 1 indexed citations
4.
Semple, Patrick, et al.. (2008). Exposure of Cord Blood toMycobacterium bovisBCG Induces an Innate Response but Not a T-Cell Cytokine Response. Clinical and Vaccine Immunology. 15(11). 1666–1673. 24 indexed citations
5.
Raju, Bindu, Yoshihiko Hoshino, Ilana Belitskaya‐Lévy, et al.. (2007). Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis. 88(1). 39–51. 47 indexed citations
6.
McIlleron, Helen, et al.. (2007). Rifampin levels, interferon-gamma release and outcome in complicated pulmonary tuberculosis. Tuberculosis. 87(6). 557–564. 9 indexed citations
7.
Davids, Virginia, Willem A. Hanekom, Nazma Mansoor, et al.. (2006). The Effect of Bacille Calmette‐Guérin Vaccine Strain and Route of Administration on Induced Immune Responses in Vaccinated Infants. The Journal of Infectious Diseases. 193(4). 531–536. 106 indexed citations
8.
Kampmann, Beate, Cheryl Hemingway, Alick Stephens, et al.. (2005). Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. Journal of Clinical Investigation. 115(9). 2480–2488. 179 indexed citations
9.
Hanekom, Willem A., Jane Hughes, Hoyam Gamieldien, et al.. (2004). Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. Journal of Immunological Methods. 291(1-2). 185–195. 133 indexed citations
10.
Hussey, Gregory, E Goddard, Sean Gottschalk, et al.. (2002). Neonatal mycobacterial specific cytotoxic T‐lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology. 105(3). 314–324. 81 indexed citations
11.
Passmore, Jo‐Ann S., Pauline T. Lukey, & Stanley Ress. (2001). The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen‐specific cytotoxic T‐cell function. Immunology. 102(2). 146–156. 57 indexed citations
12.
Doran, James L., Pattama Ekpo, Alan D. Roberts, et al.. (1999). Identification of novel immunogenicMycobacterium tuberculosispeptides that stimulate mononuclear cells from immune donors. FEMS Microbiology Letters. 177(1). 123–130. 4 indexed citations
13.
Lukey, Pauline T., et al.. (1996). Memory lymphocytes from tuberculous effusions: purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression. Clinical & Experimental Immunology. 104(3). 412–418. 8 indexed citations
14.
Ratcliffe, L, Pauline T. Lukey, O. L. Meyers, & Stanley Ress. (1995). PROSTANOID MODULATION OF SYNOVIAL ANTIGEN-SPECIFIC CD4+ T-CELL CYTOTOXIC FUNCTION IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 34(2). 113–120. 6 indexed citations
15.
Bulvik, Shlomo, Ingrid Aronson, Stanley Ress, & Peter Jacobs. (1995). Extensive bone marrow necrosis associated with antiphospholipid antibodies. The American Journal of Medicine. 98(6). 572–574. 30 indexed citations
16.
Ratcliffe, L, Pauline T. Lukey, Colin R. MacKenzie, & Stanley Ress. (1994). Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis. Clinical & Experimental Immunology. 97(3). 373–379. 36 indexed citations
17.
Ratcliffe, L, Colin R. MacKenzie, Pauline T. Lukey, & Stanley Ress. (1992). Reduced Natural Killer Cell Activity in Multi‐Drug Resistant Pulmonary Tuberculosis. Scandinavian Journal of Immunology. 36(s1). 167–170. 8 indexed citations
18.
19.
Ress, Stanley, et al.. (1991). HLA class II induction by interferon-γ in K562 variant cell line: inhibition by serum lipid. Human Immunology. 31(1). 57–66. 3 indexed citations
20.
Ress, Stanley, et al.. (1986). Laboratory assessment of immune status: uses and limitations. International Journal of Clinical Practice. 40(7). 288–291. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Klucar Breakdown of academic impact, for papers by T H Rea Breakdown of academic impact, for papers by T. Kardjito Breakdown of academic impact, for papers by Sok Thim Breakdown of academic impact, for papers by Ellen S. DeCarlo Breakdown of academic impact, for papers by Rosa Musella Breakdown of academic impact, for papers by D Kumararatne Breakdown of academic impact, for papers by Marwou de Kock Breakdown of academic impact, for papers by Patricia Gorak‐Stolinska Breakdown of academic impact, for papers by Victoria Schauf
Rankless by CCL
2026